US15135B1017 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 125.982B 13.38% | 144.547B 14.74% | 153.999B 6.54% | 147.912B -3.95% | |||||||
EBITDA YoY % growth | 4.964B -0.58% | 5.397B 8.72% | 4.9B -9.21% | 5.016B 2.37% | N/A | N/A | N/A | N/A | |||
EBIT YoY % growth | 3.488B -6.59% | 3.844B 10.21% | 3.607B -6.17% | 3.953B 9.59% | N/A | N/A | N/A | N/A | |||
Operating Margin | 2.77% | 2.66% | 2.34% | 2.67% | N/A | N/A | N/A | N/A | |||
EPS YoY % growth | 5.15 3.41% | 5.76 11.84% | 6.66 15.63% | 6.84 2.72% |
All data in USD
Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.16 2.50% | |||||||||||
Revenue Q2Q % growth | 36.888B -5.15% | |||||||||||
EBITDA Q2Q % growth | 1.5B | |||||||||||
EBIT Q2Q % growth | 1.32B 4.68% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 0.45 -47.67% | 0.44 | 0.01 | 2.42% |
Q3 2023 Q2Q % growth | 2.00 53.85% | 1.58 | 0.42 | 26.42% |
Q2 2023 Q2Q % growth | 2.10 18.64% | 2.05 | 0.05 | 2.28% |
Q1 2023 Q2Q % growth | 2.11 15.30% | 2.12 | -0.01 | -0.24% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q4 2023 Q2Q % growth | 39.46B 10.96% | 36.502B | 2.958B | 8.10% |
Q3 2023 Q2Q % growth | 38.042B 6.07% | 36.541B | 1.501B | 4.11% |
Q2 2023 Q2Q % growth | 37.608B 4.65% | 36.839B | 769M | 2.09% |
Q1 2023 Q2Q % growth | 38.889B 4.58% | 36.387B | 2.502B | 6.88% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 0.56% | -0.02% | -0.55% | 0.06% |
Revenue | 0.02% | 1.73% | 1.89% | 3.08% |